Global Hemp Group Adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC

Stock Information for Global Hemp Group Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Global Hemp Group Inc

Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing
Global Hemp Group Announces Private Placement and Corporate Update
Global Hemp Group Announces Execution of Exclusive Option Agreement to Acquire Serres Theriault (2021) Inc. ("STI"), a Multi-Facetted, Vertically Integrated Cannabis Operator in New Brunswick and Announces Private Placement
Global Hemp Group Concludes First U.S. Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP
Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property
Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor
Global Hemp Group Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at MD Anderson Cancer Center, as Its Chief Scientific Advisor
Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.